SCHEMBL24319672

SCHEMBL24319672

CCCCCCNC(O)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 1/20 0.47
EPHX1 P07099 9/20 0.39
USP2 O75604 1/20 0.37
TSHR P16473 2/20 0.37
LMNA P02545 3/20 0.36
MEN1 O00255 1/20 0.36
XBP1 P17861 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ABCB11 O95342 1/20 0.36
EGFR P00533 1/20 0.36
ESR1 P03372 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
FYN P06241 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CYP3A4 P08684 1/20 0.36
HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23676953 0.81 EPHX1 (0.45) ALDH1A1KDM4EEPHX1USP2TSHR
SCHEMBL27590750 0.80 KDM4E (0.42) ALDH1A1KDM4EEPHX1USP2TSHR
SCHEMBL7158082 0.78 EPHX1 (0.42) ALDH1A1KDM4EEPHX1TSHRADH1B
SCHEMBL28099092 0.76 ALDH1A1 (0.51) ALDH1A1KDM4EEPHX1USP2TSHR
SCHEMBL27951235 0.76 ALDH1A1 (0.51) ALDH1A1KDM4EEPHX1USP2TSHR
SCHEMBL222261 0.76 ALDH1A1 (0.51) ALDH1A1KDM4EEPHX1USP2TSHR
SCHEMBL9335245 0.75 EPHX1 (0.48) ALDH1A1KDM4EEPHX1TSHRLMNA
SCHEMBL27489037 0.75 EPHX1 (0.48) ALDH1A1KDM4EEPHX1TSHRLMNA
SCHEMBL28300972 0.75 EPHX1 (0.48) ALDH1A1KDM4EEPHX1TSHRLMNA
SCHEMBL15279337 0.75 ALDH1A1 (0.41) ALDH1A1KDM4EEPHX1USP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024050742-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING KRAS G12D VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2024-03-14 WO disclosed
WO-2022067106-A1 CRYSTALLINE POLYMORPH FORM A OF A JAK INHIBITOR AND METHODS FOR ITS PREPARATION ACLARIS THERAPEUTICS, INC. (US) 2022-03-31 WO disclosed